(Q41597581)

English

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on November 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

author name string

D. C. Montefiori

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

B. S. Graham

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

S. Kliks

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

P. F. Wright

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1287035

9 September 2022

publication date

1 November 1992

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

429-439

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

https://scigraph.springernature.com/pub.10.1007/bf00918855

0 references

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune enhancement of viral infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotypic restriction of the antibody response to human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of AIDS virus envelope gene in recombinant vaccinia viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of HIV infection prior to IgG antibody seropositivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifusion activity in sera from persons infected with human immunodeficiency virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of HIV infection by passive immunization with HIV immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00918855

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41597581&oldid=1892460799"